Clinuvel Pharmaceuticals Limited
CLVLF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $224 | $184 | $157 | $122 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $27 | $26 | $22 | $16 |
| Inventory | $9 | $11 | $10 | $2 |
| Other Curr. Assets | $3 | $1 | $1 | $1 |
| Total Curr. Assets | $263 | $222 | $190 | $141 |
| Property Plant & Equip (Net) | $7 | $8 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | -$1 | -$0 |
| Tax Assets | $1 | $0 | $1 | $0 |
| Other NC Assets | $0 | $1 | $1 | $0 |
| Total NC Assets | $9 | $9 | $4 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $272 | $231 | $194 | $144 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $3 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $16 | $16 | $7 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $24 | $7 | $6 | $6 |
| Total Curr. Liab. | $27 | $25 | $25 | $14 |
| LT Debt | $0 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $2 | $3 | $4 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $3 | $4 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $31 | $28 | $29 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $169 | $169 | $152 | $152 |
| Retained Earnings | $64 | $30 | -$10 | -$38 |
| AOCI | $8 | $4 | $23 | $12 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $241 | $203 | $165 | $126 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $272 | $231 | $194 | $144 |
| Net Debt | -$224 | -$183 | -$156 | -$120 |